ZBH
ZIMMER BIOMET HOLDINGS, INC.
Company overview
- Market capitalization
- $17.48B
- Employees
- 17,000
- Latest publication
- 2026-09-29
About ZIMMER BIOMET HOLDINGS, INC.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,177,000,000USD | 2,086,700,000USD | 2,243,800,000USD | 2,001,400,000USD | 2,077,300,000USD | 1,909,100,000USD | 2,023,200,000USD | 1,824,200,000USD |
| Cost Of Revenue | 635,500,000USD | 576,200,000USD | — | 559,300,000USD | 592,200,000USD | 549,800,000USD | 586,700,000USD | 538,600,000USD |
| Gross Profit | 1,541,500,000USD | 1,510,500,000USD | 1,273,700,000USD | 1,442,100,000USD | 1,485,100,000USD | 1,359,300,000USD | 1,436,500,000USD | 1,285,600,000USD |
| Research Development | 104,800,000USD | 103,400,000USD | 118,800,000USD | 115,900,000USD | 113,300,000USD | 110,600,000USD | 108,500,000USD | 111,600,000USD |
| Selling General Administrative | 899,300,000USD | 849,900,000USD | 872,300,000USD | 811,400,000USD | 814,800,000USD | 758,800,000USD | 746,900,000USD | 709,700,000USD |
| Total Operating Expenses | 1,215,400,000USD | 1,137,300,000USD | — | 1,090,800,000USD | 1,185,100,000USD | 1,067,000,000USD | 1,047,500,000USD | 1,006,100,000USD |
| Operating Income | 326,100,000USD | 373,200,000USD | 154,500,000USD | 351,300,000USD | 300,000,000USD | 292,300,000USD | 389,000,000USD | 279,500,000USD |
| Total Other Income Expense Net | -71,000,000USD | -71,900,000USD | — | -72,100,000USD | -75,400,000USD | -63,300,000USD | -100,000,000USD | -49,200,000USD |
| Net Interest Income | -72,900,000USD | -68,800,000USD | — | -75,400,000USD | -79,300,000USD | -66,200,000USD | -61,900,000USD | -54,300,000USD |
| Litigation Settlement Expense | 17,800,000USD | 5,000,000USD | — | 3,100,000USD | — | — | — | — |
| Income Before Tax | 255,100,000USD | 301,300,000USD | 98,000,000USD | 279,200,000USD | 224,600,000USD | 229,000,000USD | 289,000,000USD | 230,300,000USD |
| Income Tax Expense | 55,500,000USD | 63,000,000USD | 39,900,000USD | 48,000,000USD | 71,200,000USD | 46,500,000USD | 48,900,000USD | -18,900,000USD |
| Net Income | 199,600,000USD | 238,300,000USD | 137,900,000USD | 231,200,000USD | 152,800,000USD | 182,000,000USD | 239,500,000USD | 249,100,000USD |
| Minority Interest | 1,300,000USD | 200,000USD | — | 300,000USD | -600,000USD | -600,000USD | -700,000USD | -200,000USD |
| Net Income Applicable To Common Shares | 198,300,000USD | 238,100,000USD | — | 230,900,000USD | 152,800,000USD | 182,000,000USD | 239,500,000USD | 249,100,000USD |
| Unclassified Operating Expenses | — | — | — | — | 257,000,000USD | 197,600,000USD | 192,100,000USD | 184,800,000USD |
| Interest Income | — | — | — | — | 79,300,000USD | 66,200,000USD | 61,900,000USD | 54,300,000USD |
| Interest Expense | — | — | — | — | 79,300,000USD | 66,200,000USD | 61,900,000USD | 54,300,000USD |
| Tax Provision | — | — | — | — | 71,200,000USD | 46,500,000USD | 48,900,000USD | -18,900,000USD |
| Net Income From Continuing Ops | — | — | — | — | 153,400,000USD | 182,600,000USD | 240,100,000USD | 249,200,000USD |
| Ebit | — | — | — | — | 303,900,000USD | 295,200,000USD | 350,900,000USD | 284,600,000USD |
| Ebitda | — | — | — | — | 575,700,000USD | 549,600,000USD | 614,500,000USD | 535,500,000USD |
| Depreciation And Amortization | — | — | — | — | 271,800,000USD | 254,400,000USD | 263,600,000USD | 250,900,000USD |
| Reconciled Depreciation | — | — | — | — | 271,800,000USD | 254,400,000USD | 263,600,000USD | 250,900,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8,231,500,000USD | 7,678,600,000USD | 7,394,200,000USD | 6,939,900,000USD | 6,827,300,000USD | 7,932,900,000USD | 7,803,300,000USD | 7,668,400,000USD |
| Cost Of Revenue | 2,493,700,000USD | 2,191,200,000USD | 2,083,800,000USD | 2,019,500,000USD | 1,960,400,000USD | 2,271,900,000USD | 2,132,900,000USD | 2,381,800,000USD |
| Gross Profit | 5,737,800,000USD | 5,487,400,000USD | 5,310,400,000USD | 4,920,400,000USD | 4,866,900,000USD | 5,661,000,000USD | 5,670,400,000USD | 5,286,600,000USD |
| Research Development | 458,500,000USD | 437,400,000USD | 458,700,000USD | 406,000,000USD | 435,800,000USD | 391,700,000USD | 369,900,000USD | 365,600,000USD |
| Selling General Administrative | 3,257,200,000USD | 2,929,800,000USD | 2,843,700,000USD | 2,761,700,000USD | 3,323,900,000USD | 3,379,300,000USD | 3,369,700,000USD | 2,944,600,000USD |
| Total Operating Expenses | 4,639,700,000USD | 4,201,700,000USD | 4,032,700,000USD | 4,224,100,000USD | 4,006,600,000USD | 5,627,200,000USD | 4,871,100,000USD | 4,465,500,000USD |
| Operating Income | 1,098,100,000USD | 1,285,700,000USD | 1,277,700,000USD | 696,300,000USD | 860,300,000USD | 33,800,000USD | 799,300,000USD | 821,100,000USD |
| Total Other Income Expense Net | -267,300,000USD | -249,100,000USD | -210,400,000USD | -292,800,000USD | -361,300,000USD | -304,900,000USD | -334,700,000USD | -421,500,000USD |
| Net Interest Income | -292,800,000USD | -218,000,000USD | -193,500,000USD | -164,800,000USD | -208,400,000USD | -289,300,000USD | -325,300,000USD | -355,000,000USD |
| Litigation Settlement Expense | 22,700,000USD | — | — | — | — | — | — | — |
| Income Before Tax | 830,800,000USD | 1,036,600,000USD | 1,067,300,000USD | 403,500,000USD | 499,000,000USD | -271,100,000USD | 464,600,000USD | 399,600,000USD |
| Income Tax Expense | 125,700,000USD | 131,400,000USD | 42,200,000USD | 112,300,000USD | 53,500,000USD | 108,200,000USD | -1,348,800,000USD | 95,000,000USD |
| Net Income | 705,100,000USD | 903,800,000USD | 1,024,000,000USD | 231,400,000USD | 401,600,000USD | -379,200,000USD | 1,813,800,000USD | 305,900,000USD |
| Minority Interest | -100,000USD | -1,500,000USD | -900,000USD | -1,000,000USD | -500,000USD | -100,000USD | -400,000USD | -1,300,000USD |
| Unclassified Operating Expenses | — | 834,500,000USD | 730,300,000USD | 1,056,400,000USD | 246,900,000USD | 1,856,200,000USD | 866,500,000USD | 1,155,300,000USD |
| Interest Income | — | 218,000,000USD | 201,200,000USD | 164,800,000USD | 208,400,000USD | 3,300,000USD | 2,200,000USD | 2,900,000USD |
| Interest Expense | — | 218,000,000USD | 201,200,000USD | 164,800,000USD | 208,400,000USD | 289,300,000USD | 325,300,000USD | 355,000,000USD |
| Tax Provision | — | 131,400,000USD | 232,800,000USD | 112,300,000USD | 16,300,000USD | 108,200,000USD | -1,348,800,000USD | 95,000,000USD |
| Net Income From Continuing Ops | — | 905,200,000USD | 475,200,000USD | 291,200,000USD | 402,100,000USD | -379,300,000USD | 1,813,400,000USD | 304,600,000USD |
| Ebit | — | 1,254,600,000USD | 1,268,500,000USD | 568,300,000USD | 707,400,000USD | 18,200,000USD | 789,900,000USD | 754,600,000USD |
| Ebitda | — | 2,250,900,000USD | 2,220,200,000USD | 1,494,700,000USD | 1,645,100,000USD | 1,058,700,000USD | 1,852,600,000USD | 1,793,900,000USD |
| Depreciation And Amortization | — | 996,300,000USD | 951,700,000USD | 926,400,000USD | 937,700,000USD | 1,040,500,000USD | 1,062,700,000USD | 1,039,300,000USD |
| Reconciled Depreciation | — | 996,300,000USD | 939,000,000USD | 926,400,000USD | 1,067,400,000USD | 1,040,500,000USD | 1,062,700,000USD | — |
| Net Income Applicable To Common Shares | — | 903,800,000USD | 1,024,000,000USD | 231,400,000USD | 401,600,000USD | -379,200,000USD | 1,813,800,000USD | 305,900,000USD |
| Non Operating Income Net Other | — | — | — | -128,000,000USD | -153,300,000USD | -15,600,000USD | -16,100,000USD | -68,400,000USD |
| Discontinued Operations | — | — | — | -58,800,000USD | -43,400,000USD | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | 265,000,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 22,797,800,000USD | 22,721,600,000USD | 23,091,700,000USD | 23,488,000,000USD | 22,865,100,000USD | 22,183,900,000USD | 21,365,300,000USD | 21,720,300,000USD |
| Cash And Equivalents | 410,000,000USD | 424,200,000USD | 591,900,000USD | 1,292,700,000USD | 556,900,000USD | 1,384,500,000USD | 525,500,000USD | 569,000,000USD |
| Total Current Assets | 5,096,700,000USD | 4,962,500,000USD | 5,119,900,000USD | 5,834,900,000USD | 5,053,900,000USD | 5,590,200,000USD | 4,671,500,000USD | 4,864,000,000USD |
| Other Current Assets | 646,900,000USD | 562,900,000USD | 537,300,000USD | 460,300,000USD | 431,500,000USD | 428,100,000USD | 430,000,000USD | 444,800,000USD |
| Other Non Current Assets | 1,083,300,000USD | 1,067,900,000USD | 1,100,300,000USD | 1,017,200,000USD | — | — | — | — |
| Total Liabilities | 10,165,300,000USD | 10,040,000,000USD | 10,386,000,000USD | 10,722,000,000USD | — | — | — | — |
| Total Current Liabilities | 3,013,500,000USD | 2,864,300,000USD | 2,583,700,000USD | 2,402,900,000USD | 2,699,500,000USD | 2,294,900,000USD | 2,450,900,000USD | 3,571,300,000USD |
| Other Current Liabilities | 1,125,300,000USD | 1,033,300,000USD | 1,693,600,000USD | 1,487,600,000USD | — | — | — | — |
| Other Non Current Liabilities | 638,700,000USD | 630,700,000USD | 626,100,000USD | 806,400,000USD | — | — | — | — |
| Total Stockholder Equity | 12,623,900,000USD | 12,673,300,000USD | 12,697,700,000USD | 12,756,500,000USD | 12,525,000,000USD | 12,395,100,000USD | 12,468,100,000USD | 12,374,700,000USD |
| Total Equity Including Noncontrolling Interest | 12,632,500,000USD | 12,681,600,000USD | 12,705,800,000USD | 12,766,000,000USD | — | — | — | — |
| Short Long Term Debt | 2,403,000,000USD | 2,351,800,000USD | 1,174,200,000USD | 1,200,000,000USD | 820,000,000USD | 600,000,000USD | 863,000,000USD | 1,713,000,000USD |
| Long Term Debt | 6,277,500,000USD | 6,295,100,000USD | 6,932,000,000USD | 7,512,600,000USD | 6,752,500,000USD | 6,576,300,000USD | 5,341,600,000USD | 4,859,500,000USD |
| Net Receivables | 1,769,500,000USD | 1,728,600,000USD | 1,704,400,000USD | 1,598,300,000USD | 1,611,300,000USD | 1,533,400,000USD | 1,480,700,000USD | 1,481,500,000USD |
| Inventory | 2,270,300,000USD | 2,246,800,000USD | 2,286,400,000USD | 2,483,700,000USD | 2,454,200,000USD | 2,244,200,000USD | 2,235,300,000USD | 2,368,700,000USD |
| Property Plant Equipment Net | 2,236,800,000USD | 2,211,700,000USD | 2,411,300,000USD | 2,194,300,000USD | 2,175,700,000USD | 2,064,900,000USD | 2,048,800,000USD | 2,107,200,000USD |
| Goodwill | 9,919,500,000USD | 9,931,800,000USD | 9,947,100,000USD | 9,702,000,000USD | — | — | — | — |
| Intangible Assets | 4,461,600,000USD | 4,547,600,000USD | 4,717,300,000USD | 4,739,700,000USD | 4,890,800,000USD | 4,468,000,000USD | 4,598,400,000USD | 4,665,300,000USD |
| Accounts Payable | 352,400,000USD | 361,200,000USD | 303,000,000USD | 315,300,000USD | 348,700,000USD | 301,300,000USD | 194,600,000USD | 322,400,000USD |
| Common Stock | 3,200,000USD | 3,200,000USD | 3,200,000USD | 3,200,000USD | 3,200,000USD | 3,200,000USD | 3,200,000USD | 3,200,000USD |
| Retained Earnings | 11,955,100,000USD | 11,802,500,000USD | 11,611,000,000USD | 11,518,600,000USD | 11,335,200,000USD | 11,229,700,000USD | 11,095,300,000USD | 10,903,700,000USD |
| Accumulated Other Comprehensive Income | -163,900,000USD | -190,400,000USD | -205,700,000USD | -283,800,000USD | -284,500,000USD | -287,300,000USD | -262,800,000USD | -202,200,000USD |
| Short Term Debt | — | — | 57,500,000USD | — | 820,000,000USD | 600,000,000USD | 863,000,000USD | 1,713,000,000USD |
| Total Liab | — | — | — | — | 10,330,800,000USD | 9,780,100,000USD | 8,889,100,000USD | 9,337,100,000USD |
| Other Current Liab | — | — | — | — | 1,530,800,000USD | 1,393,600,000USD | 1,393,300,000USD | 1,535,900,000USD |
| Capital Stock | — | — | — | — | 3,200,000USD | 3,200,000USD | 3,200,000USD | 3,200,000USD |
| Good Will | — | — | — | — | 9,709,500,000USD | 8,988,600,000USD | 8,951,100,000USD | 8,912,300,000USD |
| Other Assets | — | — | — | — | 1,035,200,000USD | 100,000USD | 1,095,500,000USD | -100,000USD |
| Cash | — | — | — | — | 556,900,000USD | 1,384,500,000USD | 525,500,000USD | 569,000,000USD |
| Cash And Short Term Investments | — | — | — | — | 556,900,000USD | 1,384,500,000USD | 525,500,000USD | 569,000,000USD |
| Net Debt | — | — | — | — | 7,015,600,000USD | 5,791,800,000USD | 5,679,100,000USD | 5,881,700,000USD |
| Short Long Term Debt Total | — | — | — | — | 7,572,500,000USD | 7,176,300,000USD | 6,204,600,000USD | 6,450,700,000USD |
| Property Plant Equipment Gross | — | — | — | — | 7,145,500,000USD | 6,823,400,000USD | 6,690,200,000USD | 6,896,100,000USD |
| Common Stock Shares Outstanding | — | — | — | — | 198,300,000shares | 199,700,000shares | 199,900,000shares | 203,000,000shares |
| Non Current Assets Total | — | — | — | — | 17,811,200,000USD | 16,593,600,000USD | 16,693,800,000USD | 16,856,400,000USD |
| Non Current Liabilities Total | — | — | — | — | 7,631,300,000USD | 7,485,200,000USD | 6,438,200,000USD | 5,765,800,000USD |
| Non Current Liabilities Other | — | — | — | — | 878,800,000USD | 908,900,000USD | 744,100,000USD | 1,028,100,000USD |
| Non Currrent Assets Other | — | — | — | — | 1,003,000,000USD | 982,000,000USD | 1,022,300,000USD | 1,107,200,000USD |
| Net Working Capital | — | — | — | — | 2,354,400,000USD | 3,295,300,000USD | 2,220,600,000USD | 1,292,700,000USD |
| Unclassified Non Current Assets | — | — | — | — | -1,003,000,000USD | — | -1,022,300,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | -820,000,000USD | -600,000,000USD | -863,000,000USD | -1,713,000,000USD |
| Unclassified Equity | — | — | — | — | 1,467,900,000USD | 1,446,300,000USD | 1,629,200,000USD | 1,666,800,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | 352,500,000USD | -121,800,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -322,400,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 23,091,700,000USD | 21,365,300,000USD | 21,496,900,000USD | 21,066,000,000USD | 23,456,400,000USD | 24,417,700,000USD | 24,638,700,000USD | 24,126,800,000USD |
| Cash And Equivalents | 591,900,000USD | 525,500,000USD | 415,800,000USD | 375,700,000USD | 478,500,000USD | 802,100,000USD | 617,900,000USD | 542,800,000USD |
| Total Current Assets | 5,119,900,000USD | 4,671,500,000USD | 4,609,500,000USD | 4,427,300,000USD | 4,885,000,000USD | 5,083,300,000USD | 4,723,900,000USD | 4,427,400,000USD |
| Other Current Assets | 537,300,000USD | 430,000,000USD | 366,100,000USD | 522,900,000USD | 1,099,300,000USD | 377,800,000USD | 357,100,000USD | 352,300,000USD |
| Other Non Current Assets | 1,100,300,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 10,386,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,583,700,000USD | 2,450,900,000USD | 2,857,400,000USD | 2,358,200,000USD | 3,467,900,000USD | 2,556,900,000USD | 3,441,500,000USD | 2,421,300,000USD |
| Other Current Liabilities | 1,693,600,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 626,100,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 12,697,700,000USD | 12,468,100,000USD | 12,480,500,000USD | 12,020,300,000USD | 12,660,700,000USD | 12,194,200,000USD | 12,388,100,000USD | 11,271,300,000USD |
| Total Equity Including Noncontrolling Interest | 12,705,800,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 1,174,200,000USD | 863,000,000USD | 900,000,000USD | 544,300,000USD | 1,605,100,000USD | 500,000,000USD | 1,500,000,000USD | 525,000,000USD |
| Long Term Debt | 6,932,000,000USD | 5,341,600,000USD | 5,012,600,000USD | 5,152,200,000USD | 5,463,700,000USD | 7,626,500,000USD | 6,721,400,000USD | 8,413,700,000USD |
| Net Receivables | 1,704,400,000USD | 1,480,700,000USD | 1,442,400,000USD | 1,381,500,000USD | 1,259,600,000USD | 1,452,700,000USD | 1,363,900,000USD | 1,275,800,000USD |
| Inventory | 2,286,400,000USD | 2,235,300,000USD | 2,385,200,000USD | 2,147,200,000USD | 2,148,000,000USD | 2,450,700,000USD | 2,385,000,000USD | 2,256,500,000USD |
| Property Plant Equipment Net | 2,411,300,000USD | 2,048,800,000USD | 2,060,400,000USD | 1,872,500,000USD | 1,836,600,000USD | 2,047,700,000USD | 2,077,400,000USD | 2,015,400,000USD |
| Goodwill | 9,947,100,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 4,717,300,000USD | 4,598,400,000USD | 4,856,400,000USD | 5,063,800,000USD | 5,533,600,000USD | 7,055,500,000USD | 7,257,600,000USD | 7,684,600,000USD |
| Accounts Payable | 303,000,000USD | 194,600,000USD | 410,600,000USD | 354,100,000USD | 306,500,000USD | 330,000,000USD | 400,900,000USD | 362,600,000USD |
| Short Term Debt | 57,500,000USD | 863,000,000USD | 900,000,000USD | 544,300,000USD | 1,605,100,000USD | 500,000,000USD | 1,500,000,000USD | 525,000,000USD |
| Common Stock | 3,200,000USD | 3,200,000USD | 3,200,000USD | 3,100,000USD | 3,100,000USD | 3,100,000USD | 3,100,000USD | 3,100,000USD |
| Retained Earnings | 11,611,000,000USD | 11,095,300,000USD | 10,384,500,000USD | 9,559,300,000USD | 10,292,200,000USD | 10,086,900,000USD | 10,427,300,000USD | 9,491,200,000USD |
| Accumulated Other Comprehensive Income | -205,700,000USD | -262,800,000USD | -191,000,000USD | -179,300,000USD | -231,600,000USD | -297,800,000USD | -241,900,000USD | -187,400,000USD |
| Total Liab | — | 8,889,100,000USD | 9,008,800,000USD | 9,039,000,000USD | 10,790,000,000USD | 12,218,300,000USD | 12,245,900,000USD | 12,850,700,000USD |
| Other Current Liab | — | 1,393,300,000USD | 1,485,600,000USD | 1,421,300,000USD | 1,494,300,000USD | 1,522,400,000USD | 1,413,900,000USD | 1,391,300,000USD |
| Capital Stock | — | 3,200,000USD | 3,200,000USD | 3,100,000USD | 3,100,000USD | 3,100,000USD | 3,100,000USD | 3,100,000USD |
| Good Will | — | 8,951,100,000USD | 8,818,500,000USD | 8,580,200,000USD | 8,919,400,000USD | 9,261,800,000USD | 9,599,700,000USD | 9,594,400,000USD |
| Other Assets | — | 882,000,000USD | 948,300,000USD | 1,122,200,000USD | 1,062,900,000USD | 969,400,000USD | 652,900,000USD | 387,100,000USD |
| Cash | — | 525,500,000USD | 415,800,000USD | 375,700,000USD | 378,100,000USD | 802,100,000USD | 617,900,000USD | 542,800,000USD |
| Cash And Short Term Investments | — | 525,500,000USD | 415,800,000USD | 375,700,000USD | 378,100,000USD | 802,100,000USD | 617,900,000USD | 542,800,000USD |
| Net Debt | — | 5,679,100,000USD | 5,352,100,000USD | 5,320,800,000USD | 6,690,700,000USD | 7,324,400,000USD | 7,603,500,000USD | 8,395,900,000USD |
| Short Long Term Debt Total | — | 6,204,600,000USD | 5,767,900,000USD | 5,696,500,000USD | 7,068,800,000USD | 8,126,500,000USD | 8,221,400,000USD | 8,938,700,000USD |
| Property Plant Equipment Gross | — | 6,690,200,000USD | 6,766,200,000USD | 6,458,400,000USD | 6,137,700,000USD | 2,047,700,000USD | 2,077,400,000USD | 2,015,400,000USD |
| Common Stock Shares Outstanding | — | 203,900,000shares | 209,700,000shares | 210,300,000shares | 210,400,000shares | 207,000,000shares | 206,700,000shares | 203,500,000shares |
| Non Current Assets Total | — | 16,693,800,000USD | 16,887,400,000USD | 16,638,700,000USD | 18,571,400,000USD | 19,334,400,000USD | 19,914,800,000USD | 19,699,400,000USD |
| Non Current Liabilities Total | — | 6,438,200,000USD | 6,151,400,000USD | 6,680,800,000USD | 7,322,100,000USD | 9,661,400,000USD | 8,804,400,000USD | 10,429,400,000USD |
| Non Current Liabilities Other | — | 744,100,000USD | 652,200,000USD | 1,528,600,000USD | 1,858,400,000USD | 1,244,500,000USD | 1,242,900,000USD | 1,016,200,000USD |
| Non Currrent Assets Other | — | 1,022,300,000USD | 1,120,500,000USD | 1,105,600,000USD | 2,254,200,000USD | 969,400,000USD | 909,800,000USD | 366,200,000USD |
| Net Working Capital | — | 2,220,600,000USD | 1,752,100,000USD | 2,069,100,000USD | 1,417,100,000USD | 2,526,400,000USD | 1,282,400,000USD | 2,006,100,000USD |
| Unclassified Non Current Assets | — | -808,800,000USD | -916,700,000USD | -1,105,600,000USD | -1,035,300,000USD | -969,400,000USD | -643,100,000USD | -366,200,000USD |
| Unclassified Current Liabilities | — | -863,000,000USD | -838,800,000USD | -980,600,000USD | -2,588,400,000USD | -440,500,000USD | -1,373,300,000USD | -382,600,000USD |
| Unclassified Non Current Liabilities | — | 352,500,000USD | 486,600,000USD | -1,617,800,000USD | -2,524,000,000USD | -2,034,900,000USD | -1,867,500,000USD | -2,013,200,000USD |
| Unclassified Equity | — | 1,629,200,000USD | 2,280,600,000USD | 9,501,300,000USD | 9,311,700,000USD | 9,118,500,000USD | 8,917,000,000USD | 8,683,000,000USD |
| Current Deferred Revenue | — | — | -30,400,000USD | 474,800,000USD | 1,045,300,000USD | 145,000,000USD | -400,900,000USD | -362,600,000USD |
| Short Term Investments | — | — | 26,200,000USD | 6,800,000USD | 16,300,000USD | — | — | — |
| Deferred Long Term Liab | — | — | — | 474,800,000USD | 665,600,000USD | 790,400,000USD | 840,100,000USD | 999,500,000USD |
| Other Liab | — | — | — | 1,143,000,000USD | 1,858,400,000USD | 2,034,900,000USD | 1,867,500,000USD | 2,013,200,000USD |
| Treasury Stock | — | — | — | -6,867,200,000USD | -6,717,800,000USD | -6,719,600,000USD | -6,720,500,000USD | -6,721,700,000USD |
| Net Tangible Assets | — | — | — | -1,623,700,000USD | -2,825,600,000USD | -4,123,100,000USD | -4,469,200,000USD | -6,007,700,000USD |
| Long Term Investments | — | — | — | — | — | — | 60,500,000USD | 17,900,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 270,800,000USD | 270,000,000USD | — | 809,800,000USD | 271,800,000USD | 254,400,000USD | 263,600,000USD | 250,900,000USD |
| Stock Based Compensation | 24,600,000USD | 24,200,000USD | — | 66,100,000USD | 21,200,000USD | 19,600,000USD | 21,100,000USD | 24,500,000USD |
| Change To Inventory | -30,500,000USD | -20,900,000USD | — | — | -37,200,000USD | -3,000,000USD | 87,900,000USD | 3,800,000USD |
| Change To Liabilities | 92,000,000USD | -183,000,000USD | — | — | — | — | — | — |
| Change In Working Capital | -11,200,000USD | -211,300,000USD | — | — | -68,200,000USD | -73,900,000USD | 29,100,000USD | -128,800,000USD |
| Operating Cash Flow | 447,800,000USD | 359,400,000USD | 517,400,000USD | 418,700,000USD | — | — | — | — |
| Capital Expenditures | -54,200,000USD | -36,300,000USD | — | — | -80,100,000USD | -47,000,000USD | -84,900,000USD | -27,100,000USD |
| Other Investing Activities | 100,000USD | 6,200,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -136,700,000USD | -128,900,000USD | — | — | 1,336,400,000USD | 49,700,000USD | 115,500,000USD | 49,300,000USD |
| Investing Cash Flow | -190,800,000USD | -159,000,000USD | — | -1,653,700,000USD | — | — | — | — |
| Common Stock Issuance | 100,000USD | 12,300,000USD | — | — | — | — | — | — |
| Net Common Stock Issuance | -250,700,000USD | -250,100,000USD | — | — | — | — | — | — |
| Common Dividends Paid | -46,500,000USD | -46,900,000USD | — | — | — | — | — | — |
| Other Financing Activities | -2,300,000USD | -15,600,000USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 28,300,000USD | -68,900,000USD | — | — | — | — | — | — |
| Financing Cash Flow | -271,100,000USD | -369,200,000USD | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | 0USD | 1,100,000USD | — | — | — | — | — | — |
| Change In Cash | -14,200,000USD | -167,700,000USD | — | 767,200,000USD | -827,600,000USD | 859,000,000USD | -43,500,000USD | 148,900,000USD |
| End Cash Flow | 410,000,000USD | 424,200,000USD | — | 1,292,700,000USD | — | — | — | — |
| Net Income | — | — | 137,900,000USD | 231,200,000USD | 153,400,000USD | 182,600,000USD | 240,100,000USD | 249,200,000USD |
| Other Non Cash Items | — | — | — | — | 0USD | 100,000USD | -47,600,000USD | -100,000USD |
| Change To Account Receivables | — | — | — | — | 200,000USD | -18,800,000USD | -49,600,000USD | -29,900,000USD |
| Total Cash From Operating Activities | — | — | — | — | 378,200,000USD | 382,800,000USD | 506,300,000USD | 395,700,000USD |
| Free Cash Flow | — | — | — | — | 298,100,000USD | 335,800,000USD | 421,400,000USD | 368,600,000USD |
| Investments | — | — | — | — | -1,384,400,000USD | -106,000,000USD | -291,200,000USD | -154,900,000USD |
| Total Cashflows From Investing Activities | — | — | — | — | -1,384,400,000USD | -106,000,000USD | -291,200,000USD | -154,900,000USD |
| Net Borrowings | — | — | — | — | 220,000,000USD | 885,100,000USD | -113,700,000USD | 535,000,000USD |
| Total Cash From Financing Activities | — | — | — | — | 163,800,000USD | 575,400,000USD | -240,600,000USD | -101,900,000USD |
| Dividends Paid | — | — | — | — | -47,500,000USD | -47,800,000USD | -48,000,000USD | -49,200,000USD |
| Sale Purchase Of Stock | — | — | — | — | -7,200,000USD | -229,800,000USD | -72,200,000USD | -596,300,000USD |
| Begin Period Cash Flow | — | — | — | — | 1,384,500,000USD | 525,500,000USD | 569,000,000USD | 420,100,000USD |
| End Period Cash Flow | — | — | — | — | 556,900,000USD | 1,384,500,000USD | 525,500,000USD | 569,000,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | -1,256,300,000USD | -2,700,000USD | -30,600,000USD | -22,200,000USD |
| Other Cashflows From Financing Activities | — | — | — | — | -1,500,000USD | -32,100,000USD | -6,700,000USD | 8,600,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD |
|---|---|---|
| Depreciation | 540,800,000USD | 809,800,000USD |
| Stock Based Compensation | 48,800,000USD | 66,100,000USD |
| Change To Inventory | -51,400,000USD | -86,200,000USD |
| Change To Liabilities | -91,000,000USD | -11,100,000USD |
| Change In Working Capital | -222,500,000USD | -272,000,000USD |
| Operating Cash Flow | 807,200,000USD | 1,179,700,000USD |
| Capital Expenditures | -90,500,000USD | -149,700,000USD |
| Other Investing Activities | 6,300,000USD | 3,800,000USD |
| Unclassified Investing Cash Flow | -265,600,000USD | -1,507,800,000USD |
| Investing Cash Flow | -349,800,000USD | -1,653,700,000USD |
| Common Stock Issuance | 12,400,000USD | 38,000,000USD |
| Net Common Stock Issuance | -500,800,000USD | -237,000,000USD |
| Common Dividends Paid | -93,400,000USD | -142,800,000USD |
| Other Financing Activities | -17,900,000USD | -16,600,000USD |
| Unclassified Financing Cash Flow | -40,600,000USD | 1,581,400,000USD |
| Financing Cash Flow | -640,300,000USD | 1,223,000,000USD |
| Effect Of Forex Changes On Cash | 1,100,000USD | 18,200,000USD |
| Change In Cash | -181,900,000USD | 767,200,000USD |
| End Cash Flow | 410,000,000USD | 1,292,700,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 1,093,800,000USD | 996,300,000USD | 951,700,000USD | 1,032,700,000USD | 1,006,100,000USD | 1,040,500,000USD | 1,062,700,000USD | 1,039,300,000USD |
| Stock Based Compensation | 90,200,000USD | 101,000,000USD | 99,800,000USD | 79,700,000USD | 84,300,000USD | 65,500,000USD | 53,700,000USD | 57,300,000USD |
| Deferred Income Tax | -87,200,000USD | — | — | — | — | — | — | — |
| Change To Inventory | 98,200,000USD | 49,900,000USD | -240,400,000USD | -40,800,000USD | -125,200,000USD | -199,500,000USD | -120,100,000USD | 77,900,000USD |
| Change To Liabilities | 101,800,000USD | — | — | -386,200,000USD | 69,400,000USD | 5,100,000USD | 2,000,000USD | 17,800,000USD |
| Change In Working Capital | 33,400,000USD | -455,400,000USD | -396,200,000USD | -415,500,000USD | -706,200,000USD | 27,600,000USD | 64,200,000USD | -23,500,000USD |
| Operating Cash Flow | 1,697,100,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -224,500,000USD | -356,800,000USD | -394,500,000USD | -117,900,000USD | -404,700,000USD | -162,700,000USD | -156,000,000USD | -184,700,000USD |
| Other Investing Activities | 4,600,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -1,755,800,000USD | 546,600,000USD | 360,800,000USD | — | 197,600,000USD | -291,600,000USD | 169,800,000USD | -1,788,500,000USD |
| Investing Cash Flow | -1,975,700,000USD | — | — | — | — | — | — | — |
| Common Stock Issuance | 39,700,000USD | — | — | — | — | — | — | — |
| Net Common Stock Issuance | -487,000,000USD | — | — | — | — | — | — | — |
| Common Dividends Paid | -190,300,000USD | — | — | — | — | — | — | — |
| Other Financing Activities | -17,700,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 981,300,000USD | — | — | -1,604,600,000USD | -907,400,000USD | -107,900,000USD | 415,800,000USD | -126,600,000USD |
| Financing Cash Flow | 326,000,000USD | — | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | 19,000,000USD | — | — | — | — | — | — | — |
| Change In Cash | 66,400,000USD | 109,700,000USD | 40,100,000USD | 184,200,000USD | 75,100,000USD | 18,400,000USD | -109,700,000USD | -825,200,000USD |
| End Cash Flow | 591,900,000USD | — | — | — | — | — | — | — |
| Net Income | — | 905,200,000USD | 1,025,100,000USD | -137,400,000USD | 1,131,500,000USD | -379,300,000USD | 1,813,400,000USD | 304,600,000USD |
| Other Non Cash Items | — | -455,400,000USD | -2,500,000USD | 633,000,000USD | 608,800,000USD | 979,700,000USD | 364,300,000USD | 407,700,000USD |
| Change To Account Receivables | — | -89,700,000USD | -51,900,000USD | -349,100,000USD | -521,100,000USD | 213,600,000USD | 161,700,000USD | -141,600,000USD |
| Total Cash From Operating Activities | — | 1,499,400,000USD | 1,581,600,000USD | 1,204,500,000USD | 1,585,800,000USD | 1,747,400,000USD | 1,582,300,000USD | 1,632,200,000USD |
| Free Cash Flow | — | 1,142,600,000USD | 1,187,100,000USD | 1,086,600,000USD | 1,181,100,000USD | 1,584,700,000USD | 1,426,300,000USD | 1,447,500,000USD |
| Investments | — | -888,100,000USD | -670,600,000USD | 53,500,000USD | 48,100,000USD | 69,200,000USD | -510,800,000USD | 284,700,000USD |
| Total Cashflows From Investing Activities | — | -888,100,000USD | -778,900,000USD | -613,800,000USD | -729,300,000USD | -416,600,000USD | -510,800,000USD | -1,691,500,000USD |
| Net Borrowings | — | 536,300,000USD | 54,600,000USD | -275,200,000USD | -716,100,000USD | -1,154,400,000USD | -1,248,500,000USD | -269,600,000USD |
| Total Cash From Financing Activities | — | -484,500,000USD | -763,500,000USD | -421,800,000USD | -779,900,000USD | -1,302,200,000USD | -1,210,500,000USD | -743,200,000USD |
| Dividends Paid | — | -196,000,000USD | -200,900,000USD | -198,500,000USD | -196,700,000USD | -195,200,000USD | -193,600,000USD | -188,400,000USD |
| Sale Purchase Of Stock | — | -868,000,000USD | -692,200,000USD | 129,800,000USD | 158,200,000USD | 107,900,000USD | -415,500,000USD | -415,500,000USD |
| Begin Period Cash Flow | — | 415,800,000USD | 375,700,000USD | 617,900,000USD | 542,800,000USD | 524,400,000USD | 634,100,000USD | 1,459,300,000USD |
| End Period Cash Flow | — | 525,500,000USD | 415,800,000USD | 802,100,000USD | 617,900,000USD | 542,800,000USD | 524,400,000USD | 634,100,000USD |
| Other Cashflows From Investing Activities | — | -189,800,000USD | -74,600,000USD | -549,800,000USD | -570,300,000USD | -31,500,000USD | -13,800,000USD | -3,000,000USD |
| Other Cashflows From Financing Activities | — | 43,200,000USD | 75,000,000USD | 1,526,700,000USD | 882,100,000USD | 47,400,000USD | 231,300,000USD | 256,900,000USD |
| Unclassified Operating Cash Flow | — | 407,700,000USD | -96,300,000USD | — | -538,700,000USD | — | -1,776,000,000USD | -153,200,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 168,900,000USD | 76,600,000USD | 28,600,000USD | -109,700,000USD | -825,200,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | 29,300,000USD | -22,700,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Americas | 1,359,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Asia Pacific | 339,500,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | EMEA | 478,500,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Hips | 562,700,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Knees | 828,900,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | SET | 586,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Technology And Data Bone Cement And Surgical | 199,400,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Americas | 1,324,500,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific | 272,300,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 489,900,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Hips | 524,100,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Knees | 828,600,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | SET | 562,200,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Technology And Data Bone Cement And Surgical | 171,800,000 | USD | Disclosure |
| Q4 2025Quarterly · 2025-12-31 | Geography | Americas | 1,410,400,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Asia Pacific | 330,600,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | EMEA | 502,600,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Hips | 555,400,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Knees | 911,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | SET | 587,600,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Technology And Data Bone Cement And Surgical | 189,800,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Americas | 5,144,600,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Geography | Asia Pacific | 1,258,100,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Geography | EMEA | 1,828,800,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Product | Hips | 2,093,500,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Product | Knees | 3,322,300,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Product | SET | 2,150,200,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Product | Technology And Data Bone Cement And Surgical | 665,600,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Geography | Americas | 1,253,500,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Geography | Asia Pacific | 330,900,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Geography | EMEA | 417,000,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Product | Hips | 506,200,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Product | Knees | 792,400,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Product | SET | 541,500,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Product | Technology And Data Bone Cement And Surgical | 161,300,000 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Geography | Americas | 1,273,800,000 | USD | 0000950170-25-104989 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Asia Pacific | 336,100,000 | USD | 0000950170-25-104989 |
| Q2 2025Quarterly · 2025-06-30 | Geography | EMEA | 467,500,000 | USD | 0000950170-25-104989 |
| Q2 2025Quarterly · 2025-06-30 | Product | Hips | 536,100,000 | USD | 0000950170-25-104989 |
| Q2 2025Quarterly · 2025-06-30 | Product | Knees | 826,000,000 | USD | 0000950170-25-104989 |
| Q2 2025Quarterly · 2025-06-30 | Product | SET | 550,600,000 | USD | 0000950170-25-104989 |
| Q2 2025Quarterly · 2025-06-30 | Product | Technology And Data Bone Cement And Surgical | 164,600,000 | USD | 0000950170-25-104989 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Americas | 1,273,100,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Asia Pacific | 312,500,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | EMEA | 437,700,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Hips | 519,900,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Knees | 839,200,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | SET | 489,400,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Technology And Data Bone Cement And Surgical | 174,700,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Americas | 4,794,800,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Geography | Asia Pacific | 1,192,800,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Geography | EMEA | 1,691,100,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Product | Hips | 1,999,100,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Product | Knees | 3,173,500,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Product | SET | 1,865,700,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Product | Technology And Data Bone Cement And Surgical | 640,300,000 | USD | Disclosure |
| Q2 2024Quarterly · 2024-06-30 | Geography | Americas | 1,199,300,000 | USD | 0000950170-25-104989 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Asia Pacific | 310,300,000 | USD | 0000950170-25-104989 |
| Q2 2024Quarterly · 2024-06-30 | Geography | EMEA | 432,400,000 | USD | 0000950170-25-104989 |
| Q2 2024Quarterly · 2024-06-30 | Product | Hips | 506,500,000 | USD | 0000950170-25-104989 |
| Q2 2024Quarterly · 2024-06-30 | Product | Knees | 801,100,000 | USD | 0000950170-25-104989 |
| Q2 2024Quarterly · 2024-06-30 | Product | SET | 469,500,000 | USD | 0000950170-25-104989 |
| Q2 2024Quarterly · 2024-06-30 | Product | Technology And Data Bone Cement And Surgical | 164,900,000 | USD | 0000950170-25-104989 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Americas | 1,186,500,000 | USD | 0000950170-25-063509 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Asia Pacific | 258,000,000 | USD | 0000950170-25-063509 |
| Q1 2024Quarterly · 2024-03-31 | Geography | EMEA | 444,800,000 | USD | 0000950170-25-063509 |
| Q1 2024Quarterly · 2024-03-31 | Product | Hips | 491,200,000 | USD | 0000950170-25-063509 |
| Q1 2024Quarterly · 2024-03-31 | Product | Knees | 788,100,000 | USD | 0000950170-25-063509 |
| Q1 2024Quarterly · 2024-03-31 | Product | SET | 452,600,000 | USD | 0000950170-25-063509 |
| Q1 2024Quarterly · 2024-03-31 | Product | Technology And Data Bone Cement And Surgical | 157,300,000 | USD | 0000950170-25-063509 |
| FY 2023Yearly · 2023-12-31 | Geography | Americas | 4,624,100,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Geography | Asia Pacific | 1,177,700,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Geography | EMEA | 1,592,400,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Product | Hips | 1,967,200,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Product | Knees | 3,038,400,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Product | SET | 1,752,600,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Product | Technology And Data Bone Cement And Surgical | 636,000,000 | USD | Disclosure |
| FY 2022Yearly · 2022-12-31 | Geography | Americas | 4,295,500,000 | USD | 0000950170-25-026604 |
| FY 2022Yearly · 2022-12-31 | Geography | Asia Pacific | 1,187,800,000 | USD | 0000950170-25-026604 |
| FY 2022Yearly · 2022-12-31 | Geography | EMEA | 1,456,500,000 | USD | 0000950170-25-026604 |
| FY 2022Yearly · 2022-12-31 | Product | Hips | 1,894,900,000 | USD | 0000950170-25-026604 |
| FY 2022Yearly · 2022-12-31 | Product | Knees | 2,778,300,000 | USD | 0000950170-25-026604 |
| FY 2022Yearly · 2022-12-31 | Product | SET | 1,696,700,000 | USD | 0000950170-25-026604 |
| FY 2022Yearly · 2022-12-31 | Product | Technology And Data Bone Cement And Surgical | 570,000,000 | USD | 0000950170-25-026604 |
| FY 2021Yearly · 2021-12-31 | Geography | Americas | 4,102,100,000 | USD | 0000950170-24-019353 |
| FY 2021Yearly · 2021-12-31 | Geography | Asia Pacific | 1,248,000,000 | USD | 0000950170-24-019353 |
| FY 2021Yearly · 2021-12-31 | Geography | EMEA | 1,477,200,000 | USD | 0000950170-24-019353 |
| FY 2021Yearly · 2021-12-31 | Product | Hips | 1,856,100,000 | USD | 0000950170-24-019353 |
| FY 2021Yearly · 2021-12-31 | Product | Knees | 2,647,900,000 | USD | 0000950170-24-019353 |
| FY 2021Yearly · 2021-12-31 | Product | Other Product Category | 595,500,000 | USD | 0000950170-24-019353 |
| FY 2021Yearly · 2021-12-31 | Product | SET | 1,727,800,000 | USD | 0000950170-24-019353 |
| FY 2020Yearly · 2020-12-31 | Geography | Americas | 3,699,500,000 | USD | 0000950170-23-004264 |
| FY 2020Yearly · 2020-12-31 | Geography | Asia Pacific | 1,190,700,000 | USD | 0000950170-23-004264 |
| FY 2020Yearly · 2020-12-31 | Geography | EMEA | 1,237,300,000 | USD | 0000950170-23-004264 |
| FY 2020Yearly · 2020-12-31 | Product | Hips | 1,750,500,000 | USD | 0000950170-23-004264 |
| FY 2020Yearly · 2020-12-31 | Product | Knees | 2,378,300,000 | USD | 0000950170-23-004264 |
| FY 2020Yearly · 2020-12-31 | Product | Other Product Category | 473,100,000 | USD | 0000950170-23-004264 |
| FY 2020Yearly · 2020-12-31 | Product | SET | 1,525,600,000 | USD | 0000950170-23-004264 |
| FY 2019Yearly · 2019-12-31 | Geography | Americas | 4,875,800,000 | USD | 0001564590-22-007160 |
| FY 2019Yearly · 2019-12-31 | Geography | Asia Pacific | 1,359,500,000 | USD | 0001564590-22-007160 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.